Stay updated on Vobramitamab Dose Levels in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.

Latest updates to the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.5.2 added to the page, replacing the previous v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.5.0 to the record history. Removed Revision: v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedThe history now includes Revision: v3.4.3, replacing the previous entry Revision: v3.4.2.SummaryDifference0.1%

- Check75 days agoChange DetectedAdds entries for Business reasons and Terminated, and records that Results were posted, including Outcome Measures and Results, along with a new revision (v3.4.2) and updated dates (2026-02-09 and 2026-01-21).SummaryDifference1%

- Check82 days agoChange DetectedAdded a government funding status notice and updated the revision tag to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check89 days agoChange DetectedThe Record History page adds a glossary toggle and color-coded change indicators (green for additions, red for deletions). The revision label updated from v3.3.4 to v3.4.0 and the No FEAR Act Data line was removed.SummaryDifference0.8%

Stay in the know with updates to Vobramitamab Dose Levels in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.